RARE CIK: 1515673

Ultragenyx Pharmaceutical Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−339
FY22:
−380
FY23:
−475
FY24:
−414
FY25:
−466
Change from FY21 to FY25
millions USD
FY21:
−195
FY22:
−292
FY23:
168
FY24:
−18.0
FY25:
236
Change from FY21 to FY25
millions USD
FY21:
119
FY22:
501
FY23:
388
FY24:
399
FY25:
478
millions USD
FY21:
−417
FY22:
−172
FY23:
81.0
FY24:
−35.0
FY25:
252
(positive)
Change from FY21 to FY25
millions USD
FY21:
−412
FY22:
−497
FY23:
−519
FY24:
−421
FY25:
−472

All amounts in millions USD Data source:SEC EDGAR